The impact of high protein nutritional support on clinical outcomes and treatment costs of patients with colorectal cancer

Klinicka Onkologie

Volumn 29, Issue 5, 2016, Pages 351-357

  Manasek, V ^a   Bezdek, K ^b   Foltys, A ^c   Klos, K ^d   Smitka, J ^e   Smehlik, D ^f  

^a Department of Oncology   (Czech Republic)

^b Department of Anesthesiology Hospital Nový Jičin ^*  (Czech Republic)

^c Faculty Hospital Ostrava   (Czech Republic)

^d Vitkovice Hospital A S   (Czech Republic)

^e Nutricia Advanced Medical Nutrition   (Czech Republic)

^f Health Insurance Company   (Czech Republic)

Author keywords

Colorectal cancer; High protein oral nutritional support; Perioperative care

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; ANASTOMOSIS DEHISCENCE; ARTICLE; CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; COLORECTAL CANCER; COLORECTAL SURGERY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DIETARY INTAKE; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; INFORMED CONSENT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MIDDLE AGED; MULTICENTER STUDY; NUTRITIONAL STATUS; NUTRITIONAL SUPPORT; POSTOPERATIVE COMPLICATION; PROTEIN DIET; RETROSPECTIVE STUDY; TREATMENT OUTCOME; WOUND DEHISCENCE; WOUND INFECTION; ADMINISTRATION AND DOSAGE; COLORECTAL TUMOR; DIET THERAPY; DIETARY SUPPLEMENT; ECONOMICS; ORAL DRUG ADMINISTRATION; PROTEIN INTAKE; REHABILITATION;

ADMINISTRATION, ORAL; ADULT; COLORECTAL NEOPLASMS; COLORECTAL SURGERY; DIETARY PROTEINS; DIETARY SUPPLEMENTS; HOSPITALIZATION; HUMANS; LENGTH OF STAY; NUTRITIONAL SUPPORT; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84997284810     PISSN: 0862495X     EISSN: 18025307     Source Type: Journal    
DOI: 10.14735/amko2016351     Document Type: Article

References (14)

1. Ferlay J, Steliarova-Foucher E, Lortet-Tieulenat J. Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012. Eur J Cancer 2013; 49(6): 1374-1403. doi:10.1016/j.ejca.2012.12.027.
2. OECD. Health at a Glance: Europe 2012. Paris: OECD Publishing 2012.
3. Dusek L, Muzik J, Maluskova D et al. Cancer incidence and mortality in the Czech Republic. Klin Onkol 2014; 27(6): 406-423. doi:10.14735/amko2014406.
4. Cancer.org [online]. American Cancer Society. Colorectal cancer. Available from: http//www.cancer.org/can-cer/colonandrectumcancer/detailedgurde/colorectal-cancer-survival-rates.
5. Holubec I, Liska V, Finek J. The importance of early tumor shrinkage and deepness of response in assessing the efficacy of systemic anticancer treatment with metastatic colorectal cancer. Klin Onkol 2015; 28(2): 89-93. doi:10.14735/amko201589.
6. Kwag SJ, Kim JG, Kang WK. The nutritional risk is a independent factor for postoperative morbidity in surgery for colorectal cancer. Ann Surg Treat Res 2014; 86(4): 206-211. doi:10.4174/astr.2014.86.4.206.
7. Schwegler I, von Halzen A, Gutzwiller JP et al Nutritional risk is a clinical predictor of postoperative mortality and morbidity in surgery for colorectal cancer. Br J Surg 2010; 97(1): 92-97. doi:10.1002/bjs.6805.
8. Bozzetti F, Migliavacc i S, Scotti A, et a l. Impact of cancer, type, site, stage and treatment on the nutritional status of patients. Ann Surg 1981; 196(2): 170-179.
9. Stratton RJ, Green CI Elia M. Disease-re I a ted malnutrition; an evidence-basejd approach. Wallingford: CAB International 2003.
10. Lopes Jp, Castro-Cardoso Pereira PM, dos Reis Bal-Tazar Vicente AF et al. Nutritional status assessment in colorectal cancer patient! Nutr Hosp 2013; 28(2): 412-418. doi:10.3305/nh.2013.2.2.6173.
11. Dewys WD, Begg C, Lavin PT et al. Prognostic effect :hemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am J Med 1980; 69(4): 491-497.
12. Faber J, Berkhout M, Fiedler U et al. Rapid EPA and DHA incorporation and reduced PGE2 levels after one week intervention with a medical food in cancer patients receiving radiotherapy a randomized trial. Clin Nutr 2013; 32(3): 338-345. doi:10.1016/j.cinu.20l2.09.009.
13. Kabata R Jastrzebski T, Kakol M et al. Preoperative nutritional support in cancer patients with no clinical signs of malnutrition -prospective randomized controlled trial. Support Care Cancer 2015; 23(2): 365-370. doi:10.1007/500520-014-2363-4.
14. Richter I, Dvorak J, BartoS J.The combination of noad-juvant chemoradiotherapy and epidermal growth factor receptor inhibitors in the treatment of rectal adenocarcinoma. Klin Onkol 2014; 27(3):166-172. doi:10.14735/amko2014166.